Trade CLNN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Clene Inc. (CLNN) is trading at US$3.86, down 0.52% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$55.51M. Over the past 52 weeks, CLNN has traded between US$3.25 and US$13.50. On Syfe you can trade CLNN with $0 commission and add it to your watchlist.
| Previous close | US$3.88 |
|---|---|
| Market cap | US$55.51M |
| 52-week range | US$3.25 – US$13.50 |
| Volume | 47.89K |
| Exchange | US |
Clene Inc.
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Year: 2020
Top Premarket Decliners
Jun 22, 11:32 AM · MT Newswires
Clene Insider Sold Shares Worth $604,130, According to a Recent SEC Filing
May 14, 8:17 AM · MT Newswires
Clene Inc. (CLNN) stock is trading at US$3.86, -0.52% from the previous close of US$3.88.
The market cap for Clene Inc. (CLNN) stock is approximately US$55.51M.
The 52-week high for Clene Inc. (CLNN) stock is US$13.50.
The 52-week low for Clene Inc. (CLNN) stock is US$3.25.
Clene Inc. (CLNN) does not currently pay a dividend.
Stay on top of CLNN
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
